CLINICAL_TRIALS
trial_result
· 2012-04-18
Clinical Trial Update: Biochemotherapy With Temozolomide for Metastatic Melanoma [Phase 2]
Summary
Phase 2 clinical trial update on biochemotherapy with temozolomide for metastatic melanoma has been terminated; results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Melanoma | Phase 2 | Status: TERMINATED | Results posted: 2012-04-18